SHL's SmartHeart ECG Technology Showcases Potential in US Army's Largest Field Experiment

Author: Benzinga Newsdesk | April 08, 2024 03:04am

SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX: SHLTN, ))))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions is pleased to share that in a remarkable display of innovation and operational excellence, the Company's SmartHeart®, portable 12-lead ECG technology showcased its unparalleled capabilities and successfully participated in Project Convergence – Capstone 4 (PC-C4), the largest, two-phase, "in-the-dirt" experiment to date that includes enduring objectives and learning demands evolving from the Project Convergence campaign of persistent experimentation. One key event during the experiment was a comprehensive multi-day army medical experiment held at Fort Irwin's National Training Center in the Mojave Desert amidst the challenging terrains of California's Tiefort Mountains.

Designed to revolutionize urgent cardiovascular assessment in non-traditional settings, SmartHeart® provided critical support across different roles of care, during the experiments, ensuring swift and accurate heart condition evaluations in various levels of trauma care. The SmartHeart® technology was used by a varied group of healthcare clinicians including nurses, medics and physicians amidst the rugged desert conditions, where it demonstrated its reliability, ease of use and effectiveness in extreme conditions.

PC-C4, a joint, multinational experiment hosted by the U.S. Army across multiple locations in February and March allowed military medicine to explore and integrate the latest technological innovations in a field environment. SmartHeart's inclusion in this prestigious experiment underscores the growing recognition of SHL's portable ECG technology as a game-changer in the fast-paced and demanding field of military healthcare.

Posted In: SHLT